The Added Value of Longitudinal Imaging for Preclinical In Vivo Efficacy Testing of Therapeutic Compounds against Cerebral Cryptococcosis
(2020)
Journal Article
Vanherp, L., Poelmans, J., Hillen, A., Janbon, G., Brock, M., Lagrou, K., Velde, G. V., & Himmelreich, U. (2020). The Added Value of Longitudinal Imaging for Preclinical In Vivo Efficacy Testing of Therapeutic Compounds against Cerebral Cryptococcosis. Antimicrobial Agents and Chemotherapy, 64(7), https://doi.org/10.1128/aac.00070-20
© 2020 American Society for Microbiology. All rights reserved. Brain infections with Cryptococcus neoformans are associated with significant morbidity and mortality. Cryptococcosis typically presents as meningoencephalitis or fungal mass lesions call... Read More about The Added Value of Longitudinal Imaging for Preclinical In Vivo Efficacy Testing of Therapeutic Compounds against Cerebral Cryptococcosis.